These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 6538273)
41. The role of delayed computed tomographic scanning using high doses of contrast material in detecting cerebral demyelination in patients with multiple sclerosis in relapse and remission. Brooks DJ; Carr DH; Legg NJ Br J Radiol; 1987 Mar; 60(711):295-7. PubMed ID: 3567474 [No Abstract] [Full Text] [Related]
42. Multiple sclerosis and HIV: a case of multiple sclerosis-immune reconstitution inflammatory syndrome associated with antiretroviral therapy initiation. Anand P; Saylor D Int J STD AIDS; 2018 Aug; 29(9):929-932. PubMed ID: 29466918 [TBL] [Abstract][Full Text] [Related]
44. MR imaging of multiple sclerosis: comparison with clinical and CT examinations in 74 patients. Sheldon JJ; Siddharthan R; Tobias J; Sheremata WA; Soila K; Viamonte M AJR Am J Roentgenol; 1985 Nov; 145(5):957-64. PubMed ID: 3876753 [TBL] [Abstract][Full Text] [Related]
45. Chest CT features of community-acquired respiratory viral infections in adult inpatients with lower respiratory tract infections. Shiley KT; Van Deerlin VM; Miller WT J Thorac Imaging; 2010 Feb; 25(1):68-75. PubMed ID: 20160606 [TBL] [Abstract][Full Text] [Related]
46. Atypical contrast enhancement in computed tomography of demyelinating disease. Aita JF Arch Neurol; 1982 Mar; 39(3):194-5. PubMed ID: 7065940 [No Abstract] [Full Text] [Related]
47. The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA. Paolillo A; Piattella MC; Pantano P; Di Legge S; Caramia F; Russo P; Lenzi GL; Pozzilli C J Neurol; 2004 Apr; 251(4):432-9. PubMed ID: 15083288 [TBL] [Abstract][Full Text] [Related]
48. [A case of acute multiple sclerosis mimicking tumor on the neuro-imaging studies]. Ohkawa S; Mori E; Ohsumi Y; Tabuchi M; Yamadori A Rinsho Shinkeigaku; 1992 Nov; 32(11):1277-80. PubMed ID: 1301332 [TBL] [Abstract][Full Text] [Related]
49. Characterization of Enhancing MS Lesions by Dynamic Texture Parameter Analysis of Dynamic Susceptibility Perfusion Imaging. Verma RK; Slotboom J; Locher C; Heldner MR; Weisstanner C; Abela E; Kellner-Weldon F; Zbinden M; Kamm CP; Wiest R Biomed Res Int; 2016; 2016():9578139. PubMed ID: 26885524 [TBL] [Abstract][Full Text] [Related]
50. Is size an essential criterion to define tumefactive plaque? MR features and clinical correlation in multiple sclerosis. Patriarca L; Torlone S; Ferrari F; Di Carmine C; Totaro R; di Cesare E; Splendiani A Neuroradiol J; 2016 Oct; 29(5):384-9. PubMed ID: 27531859 [TBL] [Abstract][Full Text] [Related]
51. Plaque of multiple sclerosis seen on computerized transaxial tomogram. Cole M; Ross RJ Neurology; 1977 Sep; 27(9):890-1. PubMed ID: 561346 [TBL] [Abstract][Full Text] [Related]
52. Vertebral hemangiomas in the thoracic spine of multiple sclerosis patients are connected with fewer demyelinating lesions at the same level. Possible impact on pathophysiology and clinical course. Anagnostouli M; Katsavos S; Kyrozis A; Gontika M; Voumvourakis KI; Kapaki E Neurol Res; 2016 Aug; 38(8):655-62. PubMed ID: 27625006 [TBL] [Abstract][Full Text] [Related]
53. Early diagnosis and classification in acute pancreatitis. A comparison of clinical outcome with findings at computed tomography and Ranson's prognostic signs. Hjelmqvist B; Wattsgård C; Borgström A; Lasson A; Nyman U; Aspelin P; Ohlsson K Digestion; 1989; 44(4):177-83. PubMed ID: 2632294 [TBL] [Abstract][Full Text] [Related]
54. A lesion topography-based approach to predict the outcomes of patients with multiple sclerosis treated with Interferon Beta. Galassi S; Prosperini L; Logoteta A; Hirsch MN; Fanelli F; De Giglio L; Pozzilli C Mult Scler Relat Disord; 2016 Jul; 8():99-106. PubMed ID: 27456883 [TBL] [Abstract][Full Text] [Related]
55. Considerations in diagnosing brain abscess with computerized axial tomography. Heath LK; Goldstein E; Dublin A Arch Intern Med; 1978 Apr; 138(4):628-9. PubMed ID: 637647 [TBL] [Abstract][Full Text] [Related]
56. Homogeneity of active demyelinating lesions in established multiple sclerosis. Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012 [TBL] [Abstract][Full Text] [Related]
57. Early predictors of rapidly evolving multiple sclerosis: A case report. Fernando KTM; James M J Neuroimmunol; 2017 Jun; 307():42-46. PubMed ID: 28495137 [TBL] [Abstract][Full Text] [Related]
58. FDG PET/CT in Acute Tumefactive Multiple Sclerosis Occurring in a Case of Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation. Dong A; Gao M; Wang Y; Gao L; Zuo C Clin Nucl Med; 2016 Sep; 41(9):e414-6. PubMed ID: 26909714 [TBL] [Abstract][Full Text] [Related]
59. Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment. Hatcher SE; Waubant E; Nourbakhsh B; Crabtree-Hartman E; Graves JS JAMA Neurol; 2016 Jul; 73(7):790-4. PubMed ID: 27135594 [TBL] [Abstract][Full Text] [Related]
60. Mononuclear subsets in the peripheral blood of multiple sclerosis patients in relation to results of brain gadolinium- enhancing imaging. Michałowska-Wender G; Wender M Folia Neuropathol; 2006; 44(1):67-71. PubMed ID: 16565933 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]